High rate of solitary sentinel node metastases identification by fluorescence-guided lymphatic imaging in breast cancer

Journal of Surgical Oncology

Volumn 105, Issue 2, 2012, Pages 162-166

  Hirche, Christoph ^a,b   Mohr, Zarah ^b   Kneif, Sören ^b   Murawa, Dawid ^c   Hünerbein, Michael ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Helios Hospital Berlin Buch   (Germany)

^c Wielkopolska Cancer Center   (Poland)

Author keywords

breast cancer; fluorescence; indocyanine green (ICG); isolated tumor cells; lymphatic imaging; sentinel lymph node biopsy

Indexed keywords

INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; FLUORESCENCE IMAGING; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS;

EID: 84860414507     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22075     Document Type: Article

References (34)

1. Bonnema J, van de Velde CJ,: Sentinel lymph node biopsy in breast cancer. Ann Oncol 2002; 13: 1531-1537. (Pubitemid 35331450)
2. Zavagno G, De Salvo GL, Scalco G, et al.: A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: Results of the Sentinella/GIVOM trial. Ann Surg 2008; 247: 207-213. (Pubitemid 351156760)
3. Cox CE, Pendas S, Cox JM, et al.: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 227: 645-651.
4. Cady B,: Is axillary lymph node dissection necessary in routine management of breast cancer? No. Important Adv Oncol 1996; 251-265.
5. Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15: 2345-2350. (Pubitemid 27251137)
6. Purushotham AD, Macmillan RD, Wishart GC,: Advances in axillary surgery for breast cancer-Time for a tailored approach. Eur J Surg Oncol 2005; 31: 929-931. (Pubitemid 41671103)
7. Langer I, Guller U, Berclaz G, et al.: Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: A prospective Swiss multicenter study on 659 patients. Ann Surg 2007; 245: 452-461. (Pubitemid 46673142)
8. Mansel RE, Fallowfield L, Kissin M, et al.: Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial. J Natl Cancer Inst 2006; 98: 599-609. (Pubitemid 43904843)
9. Liberman L,: Pathologic analysis of sentinel lymph nodes in breast carcinoma. Cancer 2000; 88: 971-977.
10. Maaskant AJ, van de Poll-Franse LV, Voogd AC, et al.: Stage migration due to introduction of the sentinel node procedure: A population-based study. Breast Cancer Res Treat 2009; 113: 173-179.
11. Kell MR, Burke JP, Barry M, et al. Outcome of axillary staging in early breast cancer: A meta-analysis. Breast Cancer Res Treat 2010; 120: 441-447.
12. Langer I, Guller U, Hsu-Schmitz SF, et al.: Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. Eur J Surg Oncol 2009; 35: 805-813 [Epub 2008 Nov 28].
13. Straver ME, Meijnen P, van Tienhoven G, et al.: Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol 2010; 17: 1854-1861.
14. Tousimis E, Van Zee KJ, Fey JV, et al.: The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. J Am Coll Surg 2003; 197: 529-535. (Pubitemid 38223835)
15. Hirche C, Dresel S, Krempien R, et al. Sentinel node biopsy by indocyanine green retention fluorescence detection for inguinal lymph node staging of anal cancer: Preliminary experience. Ann Surg Oncol 2010; 17: 2357-2362.
16. Kitai T, Inomoto T, Miwa M, et al. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 2005; 12: 211-215.
17. Doubrovsky A, de Wilt JH, Scolyer RA, et al.: Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Ann Surg Oncol 2004; 11: 829-836.
18. Maehara Y, Oshiro T, Endo K, et al.: Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 1996; 119: 397-402. (Pubitemid 26115831)
19. Xing Y, Foy M, Cox DD, et al.: Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 2006; 93: 539-546.
20. Sandrucci S, Casalegno PS, Percivale P, et al.: Sentinel lymph node mapping and biopsy for breast cancer: A review of the literature relative to 4791 procedures. Tumori 1999; 85: 425-434. (Pubitemid 30074587)
21. Veronesi U, Paganelli G, Viale G, et al.: Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series. J Natl Cancer Inst 1999; 91: 368-373. (Pubitemid 29102337)
22. Stratmann SL, McCarty TM, Kuhn JA,: Radiation safety with breast sentinel node biopsy. Am J Surg 1999; 178: 454-457. (Pubitemid 30058290)
23. Aydogan F, Celik V, Uras C, et al.: A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg 2008; 195: 277-278.
24. Hyung WJ, Kim YS, Lim JS, et al.: Preoperative imaging of sentinel lymph nodes in gastric cancer using CT lymphography. Yonsei Med J 2010; 51: 407-413.
25. Vermeeren L, van dP I, Olmos RA, et al.: SPECT/CT for preoperative sentinel node localization. J Surg Oncol 2010; 101: 184-190.
26. Beyer F, Buerke B, Gerss J, et al.: Prediction of lymph node metastases in NSCLC. Three dimensional anatomical parameters do not substitute FDG-PET-CT. Nuklearmedizin 2010; 49: 41-48.
27. Suga K, Yuan Y, Ogasawara N, et al.: Localization of breast sentinel lymph nodes by MR lymphography with a conventional gadolinium contrast agent. Preliminary observations in dogs and humans. Acta Radiol 2003; 44: 35-42.
28. Minato M, Hirose C, Sasa M, et al.: 3-Dimensional computed tomography lymphography-guided identification of sentinel lymph nodes in breast cancer patients using subcutaneous injection of nonionic contrast medium: A clinical trial. J Comput Assist Tomogr 2004; 28: 46-51. (Pubitemid 38057854)
29. Greco M, Crippa F, Agresti R, et al.: Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: Clinical evaluation and alternative management. J Natl Cancer Inst 2001; 93: 630-635. (Pubitemid 32409630)
30. Suga K, Ogasawara N, Okada M, et al. Interstitial CT lymphography-guided localization of breast sentinel lymph node: Preliminary results. Surgery 2003; 133: 170-179. (Pubitemid 36407981)
31. Motomura K, Inaji H, Komoike Y, et al.: Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. Jpn J Clin Oncol 1999; 29: 604-607.
32. Cserni G, Bianchi S, Vezzosi V, et al.: Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions. Eur J Cancer 2008; 44: 2185-2191.
33. Stitzenberg KB, Calvo BF, Iacocca MV, et al.: Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer. Am J Clin Pathol 2002; 117: 729-737. (Pubitemid 34457007)
34. Patani N, Mokbel K,: The clinical significance of sentinel lymph node micrometastasis in breast cancer. Breast Cancer Res Treat 2009; 114: 393-402.